Cresset Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Cresset Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $381,783 - $518,047	-6,138 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$73.71 - $87.86 $452,431 - $539,284	6,138 New	6,138 $517,000
Q2 2019 Aug 12, 2019	SELL	$54.93 - $74.36 $329 - $446	-6 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$39.87 - $69.36 $637 - $1,109	-16 Reduced 72.73%	6 $0
Q4 2018 May 21, 2019	BUY	$38.89 - $77.3 $855 - $1,700	22 New	22 $1,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.15B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.